研究実績

A phase II study of perioperative capecitabine plus oxaliplatin for clinical SS/SE N1-3 M0 gastric cancer (OGSG1601)

Atsushi Yasuda, Jin Matsuyama, Tetsuji Terazawa, Masahiro Goto, Ryohei Kawabata, Shunji Endo, Motohiro Imano, Shoichiro Fujita, Yusuke Akamaru, Hirokazu Taniguchi, Mitsutoshi Tatsumi, Sang-Woong Lee,Hisato Kawakami, Yukinori Kurokawa, Toshio Shimokawa, Daisuke Sakai, Takeshi Kato, Kazumasa Fujitani, Taroh Satoh  ASCO-GI 2021, Virtual(San-Francisco, USA),15-17 Jan 2021

前の記事 次の記事 一覧ページへ戻る